Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

Optimized Vaccines to Provide Protection Against Ebola and Other Viruses

  • Read more about Optimized Vaccines to Provide Protection Against Ebola and Other Viruses
US Application 60/679,767
Filed on 2005-05-10

Method For Improving The Immune Response To DNA Vaccines To West Nile Virus (WNV) And Other Disease Targets Using Alternate Promoters

  • Read more about Method For Improving The Immune Response To DNA Vaccines To West Nile Virus (WNV) And Other Disease Targets Using Alternate Promoters
US Application 60/667,064
Filed on 2005-04-01

Identification Of A Fusion/Entry Receptor For Human Herpesvirus-8

  • Read more about Identification Of A Fusion/Entry Receptor For Human Herpesvirus-8
US Application 60/681,098
Filed on 2005-05-13

North-2'-Deoxy-Methanocarbathymidines As Antiviral Agents Against Poxviruses

  • Read more about North-2'-Deoxy-Methanocarbathymidines As Antiviral Agents Against Poxviruses
US Application 60/684,811
Filed on 2005-05-25

The HIV Gp-41-Membrane Proximal Region Arrayed on Hepatitis B Surface Antigen Particles as Novel Antigens

  • Read more about The HIV Gp-41-Membrane Proximal Region Arrayed on Hepatitis B Surface Antigen Particles as Novel Antigens
US Application 60/653,930
Filed on 2005-02-18

Negative Strand RNA Virus Replicon

  • Read more about Negative Strand RNA Virus Replicon
US Application 60/478,521
Filed on 2003-06-13

A Hexavalent Formulation Of A Bovine Or Rhesus Rotavirus-based Vaccine In A Schedule That May Eliminate Risk Of Intussusception

  • Read more about A Hexavalent Formulation Of A Bovine Or Rhesus Rotavirus-based Vaccine In A Schedule That May Eliminate Risk Of Intussusception
US Application 60/697,435
Filed on 2005-07-07

Porcine Rotovirus Gottfried-based Human Rotavirus VP4 (P1A And P12B) Single Gene Reassortant Vaccines In Addition To VP7 (G4, G5, G6, G8, G9 And G10) Single Gene Vaccines, Demonstrating Broad Reactivity

  • Read more about Porcine Rotovirus Gottfried-based Human Rotavirus VP4 (P1A And P12B) Single Gene Reassortant Vaccines In Addition To VP7 (G4, G5, G6, G8, G9 And G10) Single Gene Vaccines, Demonstrating Broad Reactivity
US Application 60/698,572
Filed on 2005-07-11

Methods and Compositions Related to the Identification of a Novel IL Inducing Protein Isolated from Toplasma gondii

  • Read more about Methods and Compositions Related to the Identification of a Novel IL Inducing Protein Isolated from Toplasma gondii
US Application 60/641,429
Filed on 2005-01-06

Monoclonal Antibodies That Broadly Neutralize Hepatitis C Virus

  • Read more about Monoclonal Antibodies That Broadly Neutralize Hepatitis C Virus
US Application 60/743,667
Filed on 2006-03-22

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 90
  • Page 91
  • Page 92
  • Page 93
  • Page 94
  • Page 95
  • Page 96
  • Page 97
  • Page 98
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health